Search Results

54 results were found

Activity Type CME Provider Title Credit Hours Fee End Date
JAMA Oncology Durability of Response to SARS-CoV-2 BNT162b2 Vaccination in Patients on Active Anticancer Treatment 1 Yes 8/19/2024
JAMA Oncology Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors 1 Yes 5/20/2024
JAMA Oncology Effects of Exercise on Cardiorespiratory Fitness and Biochemical Progression in Men With Localized Prostate Cancer Under Active Surveillance 1 Yes 10/21/2024
JAMA Oncology Efficacy and Safety of Stereotactic Radiosurgery for Brainstem Metastases 1 Yes 7/15/2024
JAMA Oncology Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida 1 Yes 3/18/2025
JAMA Oncology Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer 1 Yes 11/5/2024
JAMA Oncology Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant 1 Yes 4/22/2025
JAMA Oncology Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease 1 Yes 4/21/2025
JAMA Oncology Global Association of COVID-19 Pandemic Measures With Cancer Screening - A Systematic Review and Meta-analysis 1 Yes 8/1/2025
JAMA Oncology Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors 1 Yes 3/17/2025
JAMA Oncology Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients 1 Yes 3/18/2025
JAMA Oncology Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020 1 Yes 10/26/2025
JAMA Oncology Immune Responses to SARS-CoV-2 Among Patients With Cancer - What Can Seropositivity Tell Us? 1 Yes 6/4/2024
JAMA Oncology Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination 1 Yes 8/4/2024
JAMA Oncology Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer 1 Yes 9/23/2025
JAMA Oncology Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates 1 Yes 12/16/2024
JAMA Oncology Last Christmas Counseling Patients in the Era of COVID-19 1 Yes 4/5/2024
JAMA Oncology Last Christmas—Counseling Patients in the Era of COVID-19 1 Yes 4/5/2024
JAMA Oncology Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors 1 Yes 4/22/2025
JAMA Oncology Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors 1 Yes 1/20/2025